GPNMB and breast cancer: Specifically, increased GPNMB expression has been linked to poorer prognosis in breast cancer patients [109], and mutations in the GPNMB gene have been named as causal of the skin pigmentation disorder amyloidosis cutis dyschromica (ACD) [110].